Return to CBI Antibody Core Home Page
  Return to biothreat/emerging pathogens list
    Return to malaria parasite (malaria (P. falciparum)) ( Plasmodium falciparum ) list


malaria parasite (malaria (P. falciparum)) ( Plasmodium falciparum )
pfs230homo


Antibody Name/Abbreviation: pfs230homo
CBI Antibody Core Code: A0473

"Lot" Number: 1 Position: 100(41-140)
% Identical Homology of Target to Mouse Protein: 23% (NP_035761.1| tumor rejection antigen gp96; tumor rejection antigen (gp96) 1)
Molecular Weight of fusion protein: N.A. KDa

Target sequence used to make this antibody:
VLRSSTKKKKKKKICKSTFYVHEESEEIKSWLRNSNERDK
GKKFFIFERLIKERKYICVNKYKRNNKLKWIYKNTYEKTK
NICDDYNILFKCIKGIIYDK






Sequence Name: pfs230homo
Full name: pfs230 homolog - male specific
UniGene Number: N.A.
Accession Number: PFB0400w
Source organism: malaria parasite (malaria (P. falciparum)) ( Plasmodium falciparum )
Full length size (aa): 2508
NCBI information page:

Full length sequence:
MFIYLFIYLFFKMDKKRTFYYLFFFFTFLVYVLYFDNIKSVLRSSTKKKK
KKKICKSTFYVHEESEEIKSWLRNSNERDKGKKFFIFERLIKERKYICVN
KYKRNNKLKWIYKNTYEKTKNICDDYNILFKCIKGIIYDKNKETFFETFF
ENFWDNIFYMNKYIFNIYYYMFDYTKKVKKKIEGIKENMNIRHNNNYNNI
FYVHKFFLFNDDEEKKKRNDDIKINIKLHNNTRKLSVSEENVELKPYIKQ
GERNETVVNLYEYFTGGVKRSNNNNEIVVTSTEQFHRIVIICFKPTVKHS
HIITSPHDALNHIVEENDKIKLSEEIYSIPFYPIYGNLGLKNVITTGIVE
FMIPYFSRTQMNFTVTCANGEMNDLYKFEDLIKIRIRIPRNTKKILGLST
NEKDKTVFERIVDNTSNEYRFKSYNNKIVGIKLENSILDPPGCFKTVYED
DKILQLEVFLQYVKCINLDRDNYKIRFFFLPEDFGDEEIEFSCKFTYKKK
TSKIIFGLGETSVDKDIFYLEDEHVKLNINQDISGDEPYYSHLNYNGIPY
NICNFQYKSEYDSQVCERTIHEFSLFIYNCDTLVGTQIQTTEPITSVKYL
NSTYPINKFSDITLLSKDIDIEGLEEAFRNSKFFLTSYINHGPFPLIIEC
VISNSNKDYQNVYILLHLRTSIKNRSVSFCDFEKVQGYNYLNNYIDGKIC
NINITSNSVFGFRCPSNSIKEPKDCFSQVYIDKKVYKLNDKLSNKLILYS
MKQENLAIAGFNNYISNSFSFECYCIDKNQTYSSYERTSGEDIFNHIVKR
IHVHYKNYDELYDYNIHDKITYEPIMKNPPITYLCDFLNKKQILQPLNNK
TKNYICTIWYPKPLNYIALNCPTNRRDEQNDQTISEVYNSLQKDLLKPTG
IEQQIDQKKKELNLLFNKRNIYSNLYHLPKNAPKRTINKNGLNIVNIDEI
IPGILIKDVINMKLEDVIKPDLLTPTSFLHKTYNTNKSYLFSTRNKSTSV
FNTPSIYTPLTHTSFSISPKSVPLTKSRIEETHSSSNTYEQYIGKRNSIE
NGFFIFQLPPYLKKNQTIEFACINDSTIKNKNVGNNGIMTIHLKSFGNPI
EGCYFYKNSAKYNYLKKSIKIDDLKKEECTIRSDGEIEFVGIMCPYENNL
YLTPSSCFLKTYDNTDNLVELLDINENFEYYSNDKGISYLKIPQEFLNHV
HLFCYCNVDKDSVSDTNVLVKKENKISLELNYSNKGFNIIKTIDYQYEAD
ILIGYSYYFKRVTPIYRKKHICDFTTEDNSLEPESEDKMIYSCYLSLENN
LNFIEVKCPKNKKSSNSEWLFKYGTFDKSSEIMEDDENIKKYEHMKYMPE
DKDEIIYLFKKQKLEDILPGVIIFDKNRYFFEKGNFSFVTPLIVKEDVTI
KLLCDNSETKIDDKIGKKGIILIKIPQHITDKKFYGCDFSGDSNKKSSFY
YTSVYDLKTQNQYCEVKLKENIIISLNCPNGNINPNNCFNNVFLKTNMNE
QIHEKIQNIFDQVKVINTKSHVLLNSSSTFLIISKITKKELNFFCTCHHN
ETKNVGTIYIKNEDIINFSKAYNKESSILQYIDVTPYYLKDTYICDFTQN
HYSISFDTSVNVQNVLERYLKILSDLYNTHEEFTYFSIHLKLKKEIMKKK
YIDYLKKKINEYKEKETSDKIKRVTLSTNDNINTILVYRCNIDLGSFDKF
KIKCPSKLNEEEVENNKLYPNLIYSSNLGLDETDMLNGLTKLLYGSVLIN
KTEKNVSFFEKGELELIISPYTDSSKNIIFSCENVPRNLSKGIIGSASIF
IKKNDNKILGCDFIDTPSTLSSASTLESSYGSHASSPLSSSHHVLHNDNQ
GHDVHMINHIDISNKKNSFEFEIELIEGKNTYCNIEAIENDIVGFSCPYN
FLTTPSDCFESIQIEGVDKELETHKLEKLLKGVKILNNDIYKYNFTPSYI
ILPKKIKKSLKIFCRCNSVKLIKTGIIQINIVGDDLNNWFKKEITHNIFA
YQKMDYFYDFSKGPTNISSENVLGISTMSLMSSNKKVSRKKNHKEENRTQ
QNVYKEIENDHKNINENVNKYDNLPVTLLSSDEGDGYQADEDIGGEDDAE
DVDGEGDDEDDNILNPLRTKQVYDIIVAASEFSKIEVVCPLRNSSQFRQS
KISPENFFEYVYVLEDKNDDKRKRSIEENEKLVKAILEGKKNIDGHIINI
EDINNKKSSKNASVEYDDMGNKIFISIISEKPKAVIGDNISSSRSSVHIS
NNIMNSSFQSNIHPDPITSDTTTSEYEQYNSYFKDILVIKNINEVISFAN
IKIDINEQTYSSSLHIPPLILKDAEFLISCDNSLTLNENTRGKTATVKIK
VKSNFLKIYGCDFVGEFSTHFLFSKKWDDIPKNYICKINIQDDMLIGLAC
PSFTKLHPPDCFENIIVNQNVYKKNIIMETKNMFFYKQNDKPILSFVHVK
KILVETFLCKCYQVTKADYKEVTIQILYEPYVMGTPKYTLEKSIIQYRYA
NLKPPLHI





Questions? Click here for answers.


© Monday, February 16, 2009 by the CBI Antibody Core and the Center for Biomedical Inventions, University of Texas Southwestern Medical School.